Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(2)
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2262.2000
-44.30
(
-1.92
%)
NSE
Jun 12, 2026
15:31 PM
43.76% Gain from 52W Low
Volume:
695.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
29 Jan 2026
2262.20
-1.92%
Result Update:Gland Pharma
Buy:
Gland Pharma Ltd.
by
Axis Direct
Target: 2170 | Target met
Recommendation
Axis Direct
We maintain our BUY rating on the stock.
Gland Pharma Ltd. has an
average target
of 2288.33 from 3 brokers.
More from Gland Pharma Ltd.
Recommended
Five Interesting Stocks Today - June 12, 2026
The Baseline |
12 Jun 2026, 05:13PM
Market closes higher as Trump signals imminent peace deal with Iran
Trendlyne Marketwatch |
12 Jun 2026, 04:08PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020, 11:08AM